Trademark: 79011317
Status Date
Wednesday, January 28, 2015
Registration Number
3107099
Registration Date
Tuesday, June 20, 2006
Filing Date
Friday, January 28, 2005
Published for Opposition
Tuesday, March 28, 2006
Cancellation Date
Wednesday, January 28, 2015
5 Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, pharmaceutical preparations for the treatment of sleep disorders
Aug 21, 2015
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Aug 21, 2015
Death Of International Registration
Nov 8, 2014
Total Invalidation Processed By The Ib
Sep 20, 2014
Generic Madrid Transaction Sent To Ib
Sep 20, 2014
Generic Madrid Transaction Created
May 20, 2014
Total Invalidation Of Reg Ext Protection Created
Sep 20, 2013
Cancelled Section 71
Jul 5, 2013
Change Of Name/Address Rec'd From Ib
Mar 7, 2008
Final Decision Transaction Processed By Ib
Feb 21, 2008
Change Of Owner Received From Ib
Feb 27, 2007
Final Disposition Notice Sent To Ib
Feb 27, 2007
Final Disposition Processed
Feb 23, 2007
Final Disposition Notice Created, To Be Sent To Ib
Jun 20, 2006
Registered-Principal Register
Mar 28, 2006
Published For Opposition
Mar 8, 2006
Notice Of Publication
Feb 10, 2006
Law Office Publication Review Completed
Jan 27, 2006
Assigned To Lie
Jan 25, 2006
Approved For Pub - Principal Register
Jan 23, 2006
Teas/Email Correspondence Entered
Jan 13, 2006
Correspondence Received In Law Office
Jan 13, 2006
Teas Response To Office Action Received
Dec 16, 2005
Final Refusal Mailed
Dec 15, 2005
Final Refusal Written
Dec 15, 2005
Teas/Email Correspondence Entered
Dec 2, 2005
Correspondence Received In Law Office
Dec 2, 2005
Teas Response To Office Action Received
Sep 16, 2005
Refusal Processed By Ib
Aug 29, 2005
Non-Final Action Mailed - Refusal Sent To Ib
Aug 27, 2005
Non-Final Action (Ib Refusal) Prepared For Review
Aug 26, 2005
Non-Final Action Written
Aug 26, 2005
Assigned To Examiner
Jul 1, 2005
New Application Entered In Tram
Jun 30, 2005
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
